Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease.
Am J Gastroenterol. 2016.
PMID: 27185080
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2010 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 4 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 7 |
| 2021 | 4 |
| 2022 | 6 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 1 |
Search Results
35 results
Results by year
Citations
1
article
found by citation matching
Search results
Page 1
Weight Change and the Development of Nonalcoholic Fatty Liver Disease in Metabolically Healthy Overweight Individuals.
Clin Gastroenterol Hepatol. 2022 Mar;20(3):e583-e599. doi: 10.1016/j.cgh.2021.04.037. Epub 2021 Apr 28.
Clin Gastroenterol Hepatol. 2022.
PMID: 33930552
INTRODUCTION: The study sought to investigate the effect of weight change on hepatic steatosis (HS) incidence with or without liver fibrosis in metabolically healthy overweight or obese individuals. METHODS: A cohort of 14,779 metabolically healthy …
INTRODUCTION: The study sought to investigate the effect of weight change on hepatic steatosis (HS) incidence with or without liver f …
Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease.
Am J Gastroenterol. 2016 Aug;111(8):1133-40. doi: 10.1038/ajg.2016.178. Epub 2016 May 17.
Am J Gastroenterol. 2016.
PMID: 27185080
OBJECTIVES: The risk of nonalcoholic fatty liver disease (NAFLD) among obese individuals without obesity-related metabolic abnormalities, a condition referred to as metabolically healthy obese (MHO), is largely unexplored. ...The p …
OBJECTIVES: The risk of nonalcoholic fatty liver disease (NAFLD) among obese individuals without obesity- …
Association between metabolically healthy obesity and non-alcoholic fatty liver disease.
Hepatol Int. 2022 Dec;16(6):1412-1423. doi: 10.1007/s12072-022-10395-8. Epub 2022 Aug 20.
Hepatol Int. 2022.
PMID: 35987840
BACKGROUND: The risks of NAFLD and NAFLD with fibrosis progression among metabolically healthy obesity (MHO) individuals are largely unexplored. This cohort study investigated the association between MHO as well as other metabolic syndrome-obesity comb …
BACKGROUND: The risks of NAFLD and NAFLD with fibrosis progression among metabolically healthy obesity (MHO) individual …
Metabolically healthy and unhealthy obesity and the progression of liver fibrosis: A cross-sectional study.
Clin Res Hepatol Gastroenterol. 2021 Nov;45(6):101754. doi: 10.1016/j.clinre.2021.101754. Epub 2021 Jul 22.
Clin Res Hepatol Gastroenterol. 2021.
PMID: 34303827
BACKGROUND: The development of liver fibrosis is the most important predictor of adverse outcomes in patients with non-alcoholic fatty liver disease (NAFLD). Little is known regarding the risk factors for the progression of NAFLD t …
BACKGROUND: The development of liver fibrosis is the most important predictor of adverse outcomes in patients with non- …
Association between weight change, waist circumference change, and the risk of nonalcoholic fatty liver disease in individuals with metabolically healthy overweight or obesity and metabolically unhealthy overweight or obesity.
Obes Res Clin Pract. 2024 Mar-Apr;18(2):109-117. doi: 10.1016/j.orcp.2024.02.007. Epub 2024 Mar 4.
Obes Res Clin Pract. 2024.
PMID: 38443283
BACKGROUND: This study aimed to explore and compare the effect of weight change, and waist circumference (WC) change, on the risk of nonalcoholic fatty liver disease (NAFLD) in individuals with metabolically healthy overweight or obesi …
BACKGROUND: This study aimed to explore and compare the effect of weight change, and waist circumference (WC) change, on the risk of nona …
Editorial: Metabolically Healthy and Unhealthy Obese Children and Adolescents.
Front Endocrinol (Lausanne). 2020 Oct 28;11:613703. doi: 10.3389/fendo.2020.613703. eCollection 2020.
Front Endocrinol (Lausanne). 2020.
PMID: 33250860
Free PMC article.
No abstract available.
Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity.
Ann Hepatol. 2020 Jul-Aug;19(4):359-366. doi: 10.1016/j.aohep.2020.03.001. Epub 2020 Mar 21.
Ann Hepatol. 2020.
PMID: 32349939
Free article.
Review.
The prevalence of nonalcoholic fatty liver disease (NAFLD) is continuing to rise in many countries, paralleling the epidemic of obesity worldwide. In the last years, the concept of metabolically healthy obesity [MHO, general …
The prevalence of nonalcoholic fatty liver disease (NAFLD) is continuing to rise in many countries, paralleling …
Metabolically Healthy Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Navigating the Controversies in Disease Development and Progression.
Curr Obes Rep. 2025 May 19;14(1):46. doi: 10.1007/s13679-025-00637-9.
Curr Obes Rep. 2025.
PMID: 40387999
Free PMC article.
Review.
PURPOSE OF REVIEW: The natural course of metabolic dysfunction-associated steatotic liver disease (MASLD) in the population with metabolically healthy obesity (MHO) has not been adequately explored. ...With regard to advanced MASLD, the prevalen …
PURPOSE OF REVIEW: The natural course of metabolic dysfunction-associated steatotic liver disease (MASLD) in the population wi …
Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population.
PLoS One. 2019 Nov 4;14(11):e0224626. doi: 10.1371/journal.pone.0224626. eCollection 2019.
PLoS One. 2019.
PMID: 31682638
Free PMC article.
AIMS: The relationship between nonalcoholic fatty liver disease and incident metabolic syndrome in metabolically healthy subjects is unknown. We aimed to investigate whether nonalcoholic fatty liver disease is …
AIMS: The relationship between nonalcoholic fatty liver disease and incident metabolic syndrome in metabolica …
The presence of NAFLD influences the transition of metabolically healthy to metabolically unhealthy obesity and the ten-year cardiovascular disease risk: A population-based cohort study.
Metabolism. 2022 Mar;128:154893. doi: 10.1016/j.metabol.2021.154893. Epub 2021 Sep 30.
Metabolism. 2022.
PMID: 34600906
BACKGROUND/OBJECTIVES: We evaluated the role of the presence of non-alcoholic fatty liver disease (NAFLD) at baseline in the transition from metabolically healthy to metabolically unhealthy obesity (MHO to MUO) ten ye …
BACKGROUND/OBJECTIVES: We evaluated the role of the presence of non-alcoholic fatty liver disease (NAFLD) …
Cite